Journal of the Aerospace Medical Association Index
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Oral Manifestations of Systemic Disease Their Clinical Practice
ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease. -
Resident Scholarly Work
RESIDENT SCHOLARLY WORK Process Improvement 2020-2021 CPIP Curriculum Ongoing Projects: Alexander Gavralidis, Stephanie tin, Matthew Macey, Allisa Alport, Beenish Furquan, Justin Byrne • Unnecessary laboratory draws in patients at a Community Hospital - evaluating whether inpatients at Salem Hospital staying overnight for a social reason undergo unnecessary laboratory draws Daria Ade, Mayuri Rapolu, Usman Mughal, Eva Kubrova, Barbara Lambl, Patrick Lee • Procalcitonin utilization to tailor antibiotic use at Salem Hospital- part of Antibiotic Stewardship program Sneha Lakshman, Arturo Castro, Ashley So, George Kavalam, Hassan Kazmi, Daniela Urma, Patrick Gordan • Development of a standardized ultrasound guided central venus catheter insertion curriculum Nupur Dandawate, Farideh Davoudi , Usama Talib, Patrick Lee • Inpatient Echo utilization – guidelines updates Anneris Estevez, Usmam Mughal, Zach Abbott, Evita Joseph, Caroline Cubbison, Faith Omede, Daniela Urma • Decrease health disparities for Hispanic community at Lynn NSPG by standardizing diabetes education referral patterns and patient education Imama Ahmad, Usama Talib, Muhammad Akash, Pablo Ledesma, Patrick Lee • Inpatient Telemetry Utilization Usman Mughal, Anneris Estevez, Patrick Lee, Barbara Lambl • Health Disparities & Covid-19 Impact on Minorities, sponsored by Dr. Patrick Lee, Chair of Medicine, Dr. Barb Lambl, Infectious Disease 2017-2020 Alexander Gavralidis, Emre Tarhan, Anneris Estevez, Daniela Urma, Austin Turner, Patrick Lee • Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19 – 5/2020 implementing use of Convalescent Plasma to MGB Salem hospital in collaboration with research team. Arturo Castro-Diaz, Dr. Daniela Urma • Improving Hospital Care and Post - acute Care of SARS CoV2 patients 4/2020- 8/2020 Caroline Cubbison, Sohaib Ansari, Adam Matos • Code Status Documentation for admitted patients at Salem Hospital - Project accepted to SHM national meeting to be presented in April 2020 Caroline Cubbison, Coleen Reid, Dr. -
Impact of Oral Vitamin C on Histamine Levels and Seasickness
Journal of Vestibular Research 24 (2014) 281–288 281 DOI 10.3233/VES-140509 IOS Press Impact of oral vitamin C on histamine levels and seasickness R. Jarischa,∗,D.Weyerb,E.Ehlertb,C.H.Kochc,E.Pinkowskid, P. Junga,W.Kählerb, R. Girgensohne, J. Kowalskib, B. Weisserf and A. Kochb aFAZ Floridsdorf Allergy Center, Vienna, Austria bGerman Naval Medical Institute, Kronshagen, Germany cHavariekommando (Central Command for Maritime Emergencies), Cuxhaven, Germany dShip’s doctor, anesthesist in a private practice, Pohlheim, Germany eSanitätsamt der Bundeswehr (Medical Office of the German Armed Forces), Munich, Germany f Institute of Sports Science, Christian-Albrechts University, Kiel, Germany Received 3 July 2013 Accepted 17 December 2013 Abstract. BACKGROUND: Seasickness is a risk aboard a ship. Histamine is postulated as a causative agent, inversely related to the intake of vitamin C. Persons with mastocytosis experienced improvement of nausea after the intake of vitamin C. OBJECTIVE: To determine whether vitamin C suppresses nausea in 70 volunteers who spent 20 minutes in a life raft, exposed to one-meter-high waves in an indoor pool. METHOD: Double-blind placebo-controlled crossover study. Two grams of vitamin C or placebo was taken one hour before exposure. Blood samples were taken one hour before and after exposure to determine histamine, diamine oxidase, tryptase, and vitamin C levels. Symptom scores were noted on a visual analog scale. On the second day the test persons were asked which day they had felt better. RESULTS: Seven persons without symptoms were excluded from the analysis. Test persons had less severe symptoms after the intake of vitamin C (p<0.01). -
Prioritization of Health Services
PRIORITIZATION OF HEALTH SERVICES A Report to the Governor and the 74th Oregon Legislative Assembly Oregon Health Services Commission Office for Oregon Health Policy and Research Department of Administrative Services 2007 TABLE OF CONTENTS List of Figures . iii Health Services Commission and Staff . .v Acknowledgments . .vii Executive Summary . ix CHAPTER ONE: A HISTORY OF HEALTH SERVICES PRIORITIZATION UNDER THE OREGON HEALTH PLAN Enabling Legislatiion . 3 Early Prioritization Efforts . 3 Gaining Waiver Approval . 5 Impact . 6 CHAPTER TWO: PRIORITIZATION OF HEALTH SERVICES FOR 2008-09 Charge to the Health Services Commission . .. 25 Biennial Review of the Prioritized List . 26 A New Prioritization Methodology . 26 Public Input . 36 Next Steps . 36 Interim Modifications to the Prioritized List . 37 Technical Changes . 38 Advancements in Medical Technology . .42 CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES Practice Guidelines . 47 Age-Related Macular Degeneration (AMD) . 47 Chronic Anal Fissure . 48 Comfort Care . 48 Complicated Hernias . 49 Diagnostic Services Not Appearing on the Prioritized List . 49 Non-Prenatal Genetic Testing . 49 Tuberculosis Blood Test . 51 Early Childhood Mental Health . 52 Adjustment Reactions In Early Childhood . 52 Attention Deficit and Hyperactivity Disorders in Early Childhood . 53 Disruptive Behavior Disorders In Early Childhood . 54 Mental Health Problems In Early Childhood Related To Neglect Or Abuse . 54 Mood Disorders in Early Childhood . 55 Erythropoietin . 55 Mastocytosis . 56 Obesity . 56 Bariatric Surgery . 56 Non-Surgical Management of Obesity . 58 PET Scans . 58 Prenatal Screening for Down Syndrome . 59 Prophylactic Breast Removal . 59 Psoriasis . 59 Reabilitative Therapies . 60 i TABLE OF CONTENTS (Cont’d) CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES (CONT’D) Practice Guidelines (Cont’d) Sinus Surgery . -
CIA's Prisoners," Washington Post, 15 July 2004; "CJ.A
C06541727 Approved for Release: 2018/08/14 C06541727 Summary and Reflections of Chief of Medical Services on OMS Participation in the RDI Program 1 Approved for Release: 2018/08/14 C06541727 C06541727 Approved for Release: 2018/08/14 C06541727 . (b)(1)------ 'f'SF ~EleR~'i'/ C(b)(3) NatSecAct l/MO!'Oitlil I ' AL QA'IDA DETAINEES: the OMS Role Press attention to the Agency's interrogation and detention p~ogram began with'the 2002 capture ofAbu Zubayda~~;;lf.a~d again with the 2003 capture ofKhalid Shaykh Muhammed, accelerated in 2004 in the wake ofAbu Ghraib, and then exploded in 2(/f/lkllg,wing a number ofsignificant leaks. By 2007 hundreds-perhaps~ousan~s~f articles and editorials had been published on what ar,~ably.,has become the most controversial program in Agency history. Jji.f.;;,~dfrom withi~ resulti~g public pictur~ re~ains as ~~~a.1°fg_:.icature as fact. If tlie ~~~ i~ any guzde, however, this dzstorted pzcture~w.z!l beco.me.the accepted P.,u'b1zc history ofan important chapter in Agency kis/o_ry,:·-;:Wiih\both present'?!ind fature implications for those within the Office.o/M~dical Services. These implications warrant a more lJiy"d internal aC,;QW..t ofhow OMS understood and experienced this 'P ogr,qm at the time.~iY"· · \. ~ J• ~(. ·.~:-· /; Introduction and Contents~ [J?.:--1 J ,:.,......\.!· J.-->,,. ..... The Context {p. 2J pioo J-2@~!1J . Saving the life ofqdlfg~.[alue: Ta.rget (HVT) 'fl!. 6} {2002} Embracing SERE (Sul-viral, EvtiSion,_Resistanc~scape) [p. JO] [2002] Initiation of.',;~n_bgnced i~i!?rrogatiori. -
MEDICAL GUIDELINES for AIRLINE TRAVEL 2Nd Edition
MEDICAL GUIDELINES FOR AIRLINE TRAVEL 2nd Edition Aerospace Medical Association Medical Guidelines Task Force Alexandria, VA VOLUME 74 NUMBER 5 Section II, Supplement MAY 2003 Medical Guidelines for Airline Travel, 2nd Edition A1 Introduction A1 Stresses of Flight A2 Medical Evaluation and Airline Special Services A2 Medical Evaluation A2 Airline Special Services A3 Inflight Medical Care A4 Reported Inflight Illness and Death A4 Immunization and Malaria Prophylaxis A5 Basic Immunizations A5 Supplemental Immunizations A5 Malaria Prophylaxis A6 Cardiovascular Disease A7 Deep Venous Thrombosis A8 Pulmonary Disease A10 Pregnancy and Air Travel A10 Maternal and Fetal Considerations A11 Travel and Children A11 Ear, Nose, and Throat A11 Ear A11 Nose and sinuses A12 Throat A12 Surgical Conditions A13 Neuropsychiatry A13 Neurological A13 Psychiatric A14 Miscellaneous Conditions B14 Air Sickness B14 Anemia A14 Decompression Illness A15 Diabetes A16 Jet Lag A17 Diarrhea A17 Fractures A18 Ophthalmological Conditions A18 Radiation A18 References Copyright 2003 by the Aerospace Medical Association, 320 S. Henry St., Alexandria, VA 22314-3579 The paper used in this publication meets the minimum requirements of American National Standard for Information Sciences—Permanence of Paper for Printed Library Materials. ANSI Z39.48-1984. Medical Guidelines for Airline Travel, 2nd ed. Aerospace Medical Association, Medical Guidelines Task Force, Alexandria, VA Introduction smoke, uncomfortable temperatures and low humidity, jet lag, and cramped seating (64). Nevertheless, healthy Each year approximately 1 billion people travel by air passengers endure these stresses which, for the most on the many domestic and international airlines. It has part, are quickly forgotten once the destination is been predicted that in the coming two decades, the reached. -
Medical Guidelines for Airline Transport
Federal Aviation Administration Aeromedical Safety Considerations for Transportation of Patients by Airline Presented at: Brasilia By: Melchor J. Antuñano, M.D., M.S. Director, Civil Aerospace Medical Institute Date: 2011 INDIVIDUAL : OPERATIONAL : Physical Fitness Chemical/Biological Hazards Psychological Fitness Automation Issues Alcohol Consumption Workload & Performance Medication Use Decision-Making & Judgement Illicit Drug Use Crew Resource Management Diseases & Illnesses Spatial Disorientation Fatigue Life Support Systems Circadian Rhythms Personal Protective Equipment Nutrition & Hydration Acceleration Forces Emotional Stress Human-Machine Interface Human-Human Interface ENVIRONMENT : Noise & Vibration Barometric Pressure Airsickness Solar & Cosmic Radiation Transmeridian Flights Temperature and Humidity Cabin Air Medical Guidelines for Airline Travel Federal Aviation Administration • Cabin altitude during flight is between 5,000 and 8,000 ft (1,524 m and 2,438 m) • This results in reduced barometric pressure with a decrease in partial pressure of oxygen (PO2) • Barometric pressure is 760 mmHg at sea level with a PaO2 (arterial O2 pressure) of 98 mmHg • Barometric pressure at 8000 ft will be 565 mmHg with PaO2 of about 55 mmHg • This corresponds to a blood oxygen saturation of 90% Cabin Operation 3,048 m (8,000 ft MAX) Airplane Operation 12,192 m Typical Cruise Cabin Pressure Schedule Resulting Cabin Altitude at Cruise Depends on Airplane altitude Cruise Cabin Pressure Schedule Constant Diff Pressure Health-Related Symptoms as -
Specificity of Parotid Sialendoscopy
The Laryngoscope Lippincott Williams & Wilkins, Inc., Philadelphia © 2001 The American Laryngological, Rhinological and Otological Society, Inc. Specificity of Parotid Sialendoscopy Francis Marchal, MD; Pavel Dulguerov, MD, PD; Minerva Becker, MD; Gerard Barki; François Disant, MD; Willy Lehmann, MD Objective: To present our initial experience with INTRODUCTION sialendoscopy of the parotid duct. Study Design: An obstructive disease is the usual diagnosis in case of Methods: Diagnostic and interventional sialendos- unilateral diffuse parotid swelling (after exclusion of mumps copy procedures were performed in 79 and 55 cases, parotitis). The classic attitude is an antibiotic and anti- respectively. Diagnostic sialendoscopy was used to inflammatory treatment, followed by radiological studies, classify ductal lesions into sialolithiasis, stenosis, sia- usually sialography,1 which is still considered the gold stan- lodochitis, and polyps. Interventional sialendoscopy dard. Diagnostic sialendoscopy is a recent procedure2,3 al- was used to treat these disorders. The type of endo- scope used, the type of sialolithiasis fragmentation lowing complete visualization of the ductal system and its and/or extraction device used, the total number of diseases and disorders. Major advances in optical technolo- procedures, the type of anesthesia, and the number gies and the development of semirigid sialendoscopes are and size of the sialoliths removed were the dependent responsible for significant progress in salivary gland endos- variables. The outcome variable was the endoscopic copy.4,5 This procedure, by allowing the complete exploration clearing of the ductal tree and resolution of symp- of the salivary ductal system, is positioned to replace sialog- toms. Results: Diagnostic sialendoscopy was possible raphy and other radiological studies6 because of its higher ؎ in all cases, with an average duration of 26 14 min- specificity and cost-effectiveness. -
Article Reference
Article Specificity of parotid sialendoscopy MARCHAL, Francis, et al. Abstract To present our initial experience with sialendoscopy of the parotid duct. Reference MARCHAL, Francis, et al. Specificity of parotid sialendoscopy. Laryngoscope, 2001, vol. 111, no. 2, p. 264-71 DOI : 10.1097/00005537-200102000-00015 PMID : 11210873 Available at: http://archive-ouverte.unige.ch/unige:26081 Disclaimer: layout of this document may differ from the published version. 1 / 1 The Laryngoscope Lippincott Williams & Wilkins, Inc., Philadelphia © 2001 The American Laryngological, Rhinological and Otological Society, Inc. Specificity of Parotid Sialendoscopy Francis Marchal, MD; Pavel Dulguerov, MD, PD; Minerva Becker, MD; Gerard Barki; François Disant, MD; Willy Lehmann, MD Objective: To present our initial experience with INTRODUCTION sialendoscopy of the parotid duct. Study Design: An obstructive disease is the usual diagnosis in case of Methods: Diagnostic and interventional sialendos- unilateral diffuse parotid swelling (after exclusion of mumps copy procedures were performed in 79 and 55 cases, parotitis). The classic attitude is an antibiotic and anti- respectively. Diagnostic sialendoscopy was used to inflammatory treatment, followed by radiological studies, classify ductal lesions into sialolithiasis, stenosis, sia- usually sialography,1 which is still considered the gold stan- lodochitis, and polyps. Interventional sialendoscopy dard. Diagnostic sialendoscopy is a recent procedure2,3 al- was used to treat these disorders. The type of endo- scope used, the type of sialolithiasis fragmentation lowing complete visualization of the ductal system and its and/or extraction device used, the total number of diseases and disorders. Major advances in optical technolo- procedures, the type of anesthesia, and the number gies and the development of semirigid sialendoscopes are and size of the sialoliths removed were the dependent responsible for significant progress in salivary gland endos- variables. -
The Effects of Sopite Syndrome on Self-Paced Airsickness Desensitization Program
Calhoun: The NPS Institutional Archive Theses and Dissertations Thesis Collection 1998-09-01 The effects of Sopite Syndrome on self-paced airsickness desensitization program Flaherty, Michelle A. Monterey, California. Naval Postgraduate School http://hdl.handle.net/10945/8296 DUDLEY KNOX LIBRARY NAVAL POSTGRADUATE SCHOOL MONTEREY, CA 93943-5101 NAVAL POSTGRADUATE SCHOOL Monterey, California THESIS THE EFFECTS OF SOPITE SYNDROME ON SELF-PACED AIRSICKNESS DESENSITIZATION PROGRAM by Michelle A. Flaherty September 1998 Thesis Advisor: John K. Schmidt Co-Advisor: Robert R. Read Second Reader: Samuel E. Buttery Approved for public release; distribution is unlimited. REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instruction, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to Washington headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (0704-0188) Washington DC 20503. 1. AGENCY USE ONLY (Leave blank) 2. REPORT DATE 3. REPORT TYPE AND DATES COVERED September 1998 Master's Thesis 4. TITLE AND SUBTITLE 5. FUNDING NUMBERS THE EFFECTS OF SOPITE SYNDROME ON SELF-PACED AIRSICKNESS DESENSITIZATION PROGRAM 6. AUTHOR(S) Flaherty, Michelle A. 8. PERFORMING 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) ORGANIZATION REPORT Naval Postgraduate School NUMBER Monterey, CA 93943-5000 9. -
Evidence Report Risk of Impaired Control of Spacecraft/Associated
Evidence Report Risk of Impaired Control of Spacecraft/Associated Systems and Decreased Mobility Due to Vestibular/Sensorimotor Alterations Associated with Space flight 21 September 2015 Human Research Program Human Health & Countermeasures National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas CURRENT CONTRIBUTING AUTHORS: Jacob J. Bloomberg NASA Johnson Space Center, Houston, TX Millard F. Reschke NASA Johnson Space Center, Houston, TX Gilles R. Clément Wyle Science Technology & Engineering Group, Houston, TX Ajitkumar P. Mulavara Universities Space Research Association, Houston, TX Laura C. Taylor Wyle Science Technology & Engineering Group, Houston, TX PREVIOUS CONTRIBUTING AUTHORS: William H. Paloski NASA Johnson Space Center, Houston, TX Charles M. Oman Massachusetts Institute of Technology, Cambridge, MA Scott J. Wood Azusa Pacific University, Azusa, CA Deborah L. Harm NASA Johnson Space Center, Houston, TX Brian T. Peters Wyle Science Technology & Engineering Group, Houston, TX James P. Locke NASA Johnson Space Center, Houston, TX Leland S. Stone NASA Ames Research Center, Moffett Field, CA 2 TABLE OF CONTENTS I. PRD RISK TITLE: RISK OF IMPAIRED CONTROL OF SPACECRAFT/ASSOCIATED SYSTEMS AND DECREASED MOBILITY DUE TO VESTIBULAR/SENSORIMOTOR ALTERATIONS ASSOCIATED WITH SPACE FLIGHT................................................................................... 7 II. EXECUTIVE SUMMARY..................................................................................................... 7 III. -
Non-Neoplastic Parotid Disorders
Non-neoplastic Parotid Disorders David W. Eisele, M.D., F.A.C.S. Department of Otolaryngology- Head and Neck Surgery Johns Hopkins University School of Medicine Disclosure Nothing to disclose Objectives • Presentation • Evaluation • Classification system parotid enlargement - Inflammatory - Non-Inflammatory Non-neoplastic Parotid Disorders • Variety of clinical disorders - Primary gland disorder - Systemic disorder with gland involvement • Local symptoms +/- systemic or asymptomatic • Diagnosis generally dependent on clinical evaluation and diagnostic studies • Treatment largely guided by diagnosis and patient complaints History • Determine which salivary gland or glands are involved • Progression of enlargement • Inciting factors for enlargement • Nature and duration of symptoms • Pain: character, severity, frequency History • Associated Symptoms - Head and Neck - Systemic • Review of Systems • Medications • Past Medical History • Social History (eg. alcohol use) • Family History Physical Examination • Complete Head and Neck Exam • Inspection / Palpation of Salivary Glands - enlargement (unilateral/bilateral) - consistency - tenderness - mobility • Differentiate diffuse gland enlargement from discrete mass or anatomic anomaly Physical Examination • Cranial Nerves V, VII, X, XI, XII •Eyes - lacrimal gland enlargement - tear adequacy • Neck lymphadenopathy - unilateral or bilateral Team Approach • Radiology • Pathology / Cytopathology • Internal Medicine • Rheumatology, Endocrinology • Infectious Diseases • Pediatrics • Psychiatry • Nutrition